Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1983 Mar;23(3):450–457. doi: 10.1128/aac.23.3.450

In vitro susceptibility patterns of methicillin-resistant and-susceptible Staphylococcus auerues strains in a population of parenteral drug abusers from 1972 to 1981.

N Markowitz, D J Pohlod, L D Saravolatz, E L Quinn
PMCID: PMC184668  PMID: 6552151

Abstract

Since 1980, infections caused by methicillin-resistant (MR) Staphylococcus aureus have been epidemic among Detroit-area parenteral drug abusers. Because of the increasing importance of this pathogen, in vitro susceptibilities were compared for 39 isolates of MR S. aureus from 1980 to 1981, and for 56 strains of methicillin-susceptible (MS) S. aureus from 1972 to 1981, recovered from drug abusers with community-acquired infections. Agar dilution studies were performed at 35 degrees C, and minimal inhibitory concentrations were determined after incubation for 18 and 48 h. MR S. aureus exhibited cross-resistance to other beta-lactam antibiotics which frequently required 48 h for expression. MR S. aureus isolates were also resistant to tetracycline, clindamycin, tobramycin, and amikacin. All MR S. aureus isolates investigated synthesized an aminoglycoside 4'-nucleotidyltransferase. Emergence of resistance to cefotaxime, tetracycline, and clindamycin was noted among current MS S. aureus isolates. Vancomycin, fusidic acid, trimethoprim/sulfamethoxazole, and rifampin were the most active agents against MR S. aureus and were equally effective against MS S. aureus.

Full text

PDF
450

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett F. F., McGehee R. F., Jr, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Engl J Med. 1968 Aug 29;279(9):441–448. doi: 10.1056/NEJM196808292790901. [DOI] [PubMed] [Google Scholar]
  2. Benveniste R., Davies J. R-factor mediated gentamicin resistance: A new enzyme which modifies aminoglycoside antibiotics. FEBS Lett. 1971 May 20;14(5):293–296. doi: 10.1016/0014-5793(71)80282-x. [DOI] [PubMed] [Google Scholar]
  3. Burch K. H., Quinn E. L., Cox F., Madhavan T., Fisher E., Romig D. Intramuscular clindamycin for therapy of infective endocarditis. Report of 23 cases and review of the literature. Am J Cardiol. 1976 Dec;38(7):929–933. doi: 10.1016/0002-9149(76)90806-7. [DOI] [PubMed] [Google Scholar]
  4. CHABBERT Y. A., BAUDENS J. G. [Staphylococcus strains naturally resistant to methicillin and 5-methyl-3-phenyl-4-iso-oxazolyl-penicillin]. Ann Inst Pasteur (Paris) 1962 Aug;103:222–230. [PubMed] [Google Scholar]
  5. COLLEY E. W., MCNICOL M. W., BRACKEN P. M. METHICILLIN-RESISTANT STAPHYLOCOCCI IN A GENERAL HOSPITAL. Lancet. 1965 Mar 13;1(7385):595–597. doi: 10.1016/s0140-6736(65)91165-7. [DOI] [PubMed] [Google Scholar]
  6. Canawati H. N., Witte J. L., Sapico F. L. Temperature effect on the susceptibility of methicillin-resistant Staphylococcus aureus to four different cephalosporins. Antimicrob Agents Chemother. 1982 Jan;21(1):173–175. doi: 10.1128/aac.21.1.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Churcher G. M. A screening test for the detection of methicillin-resistant staphylococci. J Clin Pathol. 1968 Mar;21(2):213–217. doi: 10.1136/jcp.21.2.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Crossley K., Landesman B., Zaske D. An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. II. Epidemiologic studies. J Infect Dis. 1979 Mar;139(3):280–287. doi: 10.1093/infdis/139.3.280. [DOI] [PubMed] [Google Scholar]
  9. ERIKSEN K. R., ERICHSEN I. RESISTANCE TO METHICILLIN, ISOXAZOLYL PENICILLINS, AND CEPHALOTHIN IN STAPHYLOCOCCUS AUREUS. Acta Pathol Microbiol Scand. 1964;62:255–275. doi: 10.1111/apm.1964.62.2.255. [DOI] [PubMed] [Google Scholar]
  10. Everett E. D., McNitt T. R., Rahm A. E., Jr, Stevens D. L., Peterson H. E. Epidemiologic investigation of methicillin resistant Staphylococcus aureus in a burn unit. Mil Med. 1978 Mar;143(3):165–167. [PubMed] [Google Scholar]
  11. Gopal V., Bisno A. L., Silverblatt F. J. Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations. JAMA. 1976 Oct 4;236(14):1604–1606. [PubMed] [Google Scholar]
  12. Haley R. W., Hightower A. W., Khabbaz R. F., Thornsberry C., Martone W. J., Allen J. R., Hughes J. M. The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Possible role of the house staff-patient transfer circuit. Ann Intern Med. 1982 Sep;97(3):297–308. doi: 10.7326/0003-4819-97-3-297. [DOI] [PubMed] [Google Scholar]
  13. Hallander H. O., Laurell G., Dornbusch K. Determination of methicillin resistance of Staphylococcus aureus. Heterogeneity and its influence on the disc diffusion method. Scand J Infect Dis. 1969;1(3):169–174. [PubMed] [Google Scholar]
  14. Hewitt J. H., Coe A. W., Parker M. T. The detection of methicillin resistance in Staphylococcus aureus. J Med Microbiol. 1969 Nov 4;2(4):443–456. doi: 10.1099/00222615-2-4-443. [DOI] [PubMed] [Google Scholar]
  15. Kayser F. H., Mak T. M. Methicillin-resistant staphylococci. Am J Med Sci. 1972 Sep;264(3):197–205. [PubMed] [Google Scholar]
  16. Klastersky J., Beumer J., Daneau D. Bacteriophage types and antibiotic susceptibility of Staphylococcus aureus. Appl Microbiol. 1971 Dec;22(6):1000–1007. doi: 10.1128/am.22.6.1000-1007.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Klimek J. J., Marsik F. J., Bartlett R. C., Weir B., Shea P., Quintiliani R. Clinical, epidemiologic and bacteriologic observations of an outbreak of methicillin-resistant Staphylococcus aureus at a large community hospital. Am J Med. 1976 Sep;61(3):340–345. doi: 10.1016/0002-9343(76)90370-3. [DOI] [PubMed] [Google Scholar]
  18. Kropp H., Sundelof J. G., Kahan J. S., Kahan F. M., Birnbaum J. MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities. Antimicrob Agents Chemother. 1980 Jun;17(6):993–1000. doi: 10.1128/aac.17.6.993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Le Goffic F., Martel A., Capmau M. L., Baca B., Goebel P., Chardon H., Soussy C. J., Duval J., Bouanchaud D. H. New plasmid-mediated nucleotidylation of aminoglycoside antibiotics in Staphlococcus aureus. Antimicrob Agents Chemother. 1976 Aug;10(2):258–264. doi: 10.1128/aac.10.2.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Levine D. P., Cushing R. D., Jui J., Brown W. J. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Ann Intern Med. 1982 Sep;97(3):330–338. doi: 10.7326/0003-4819-97-3-330. [DOI] [PubMed] [Google Scholar]
  21. O'Toole R. D., Drew W. L., Dahlgren B. J., Beaty H. N. An outbreak of methicillin-resistant Staphylococcus aureus infection. Observations in hospital and nursing home. JAMA. 1970 Jul 13;213(2):257–263. [PubMed] [Google Scholar]
  22. PARKER M. T., JEVONS M. P. A SURVEY OF METHICILLIN RESISTANCE IN STAPHYLOCOCCUS AUREUS. Postgrad Med J. 1964 Dec;40:SUPPL–SUPPL:178. doi: 10.1136/pgmj.40.suppl.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Peacock J. E., Jr, Marsik F. J., Wenzel R. P. Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Ann Intern Med. 1980 Oct;93(4):526–532. doi: 10.7326/0003-4819-93-4-526. [DOI] [PubMed] [Google Scholar]
  25. RUTENBURG A. M., GREENBERG H. L., SCHWEINBURG F. B. Clinical experiences with 2, 6-dimethoxyphenyl penicillin monohydrate in staphylococcal infections. N Engl J Med. 1960 Dec 8;263:1174–1178. doi: 10.1056/NEJM196012082632305. [DOI] [PubMed] [Google Scholar]
  26. Rountree P. M., Beard M. A. Hospital strains of Staphylococcus aureus, with particular reference to methicillin-resistant strains. Med J Aust. 1968 Dec 28;2(26):1163–1168. doi: 10.5694/j.1326-5377.1968.tb83502.x. [DOI] [PubMed] [Google Scholar]
  27. SUTHERLAND R., ROLINSON G. N. CHARACTERISTICS OF METHICILLIN-RESISTANT STAPHYLOCOCCI. J Bacteriol. 1964 Apr;87:887–899. doi: 10.1128/jb.87.4.887-899.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sabath L. D. Mechanisms of resistance to beta-lactam antibiotics in strains of Staphylococcus aureus. Ann Intern Med. 1982 Sep;97(3):339–344. doi: 10.7326/0003-4819-97-3-339. [DOI] [PubMed] [Google Scholar]
  29. Saravolatz L. D., Markowitz N., Arking L., Pohlod D., Fisher E. Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak. Ann Intern Med. 1982 Jan;96(1):11–16. doi: 10.7326/0003-4819-96-1-11. [DOI] [PubMed] [Google Scholar]
  30. Saroglou G., Cromer M., Bisno A. L. Methicillin-resistant Staphylococcus aureus: interstate spread of nosocomial infections with emergence of gentamicin-methicillin resistant strains. Infect Control. 1980 Mar-Apr;1(2):81–89. doi: 10.1017/s0195941700052590. [DOI] [PubMed] [Google Scholar]
  31. Sorrell T. C., Packham D. R., Shanker S., Foldes M., Munro R. Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann Intern Med. 1982 Sep;97(3):344–350. doi: 10.7326/0003-4819-97-3-344. [DOI] [PubMed] [Google Scholar]
  32. Thompson R. L., Fisher K. A., Wenzel R. P. In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1982 Feb;21(2):341–343. doi: 10.1128/aac.21.2.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Thornsberry C., Caruthers J. Q., Baker C. N. Effect of temperature on the in vitro susceptibility of Staphylococcus aureus to penicillinase-resistant penicillins. Antimicrob Agents Chemother. 1973 Sep;4(3):263–269. doi: 10.1128/aac.4.3.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Verbist L., Verhaegen J. In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime. Antimicrob Agents Chemother. 1981 Mar;19(3):402–406. doi: 10.1128/aac.19.3.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Watanakunakorn C., Guerriero J. C. Interaction between vancomycin and rifampin against Staphylococcus aureus. Antimicrob Agents Chemother. 1981 Jun;19(6):1089–1091. doi: 10.1128/aac.19.6.1089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Witte J. L., Sapico F. L., Canawati H. N. In vitro susceptibility of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains to N-formimidoyl thienamycin. Antimicrob Agents Chemother. 1982 Nov;22(5):906–908. doi: 10.1128/aac.22.5.906. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES